Immunic IMUX
NASDAQ IMUX
$7.96 -0.68 (-7.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunic (IMUX) Selling, General & Administrative (2013 - 2026)

Updated

Immunic (IMUX) posted Selling, General & Administrative of $9.4 million for Q2 2026, up 64.4% from $5.71 million a year earlier and up 23.5% from the prior quarter.

Analysis

Immunic (IMUX) Selling, General & Administrative (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Immunic was $27.24 million, up 40.6% year-over-year; for FY2025, it was $21.25 million, up 18.0% from FY2024.

  • Annual Selling, General & Administrative has increased for five consecutive years, with a five-year compound annual growth rate of 15.5% (FY2020 to FY2025).
  • In prior years, Immunic's Selling, General & Administrative was $18.01 million in FY2024 (+12.5%), $16.01 million in FY2023 (+4.9%), $15.26 million in FY2022 (+14.8%) and $13.3 million in FY2021 (+28.7%).
  • The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q1 2013.
  • On a year-over-year basis, Selling, General & Administrative has increased in each of the last six quarters, with growth averaging 24.4% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2026, with growth of 64.4%; the weakest was Q2 2023, with a decline of 5.5%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $7.61 million (Q1 2026), $4.26 million (Q4 2025) and $5.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Immunic 338.41 Mn 338.41 Mn - 9.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.40 Mn
Mar 31, 2026 7.61 Mn
Dec 31, 2025 4.26 Mn
Sep 30, 2025 5.98 Mn
Jun 30, 2025 5.71 Mn
Mar 31, 2025 5.29 Mn
Dec 31, 2024 4.01 Mn
Sep 30, 2024 4.36 Mn
Jun 30, 2024 4.49 Mn
Mar 31, 2024 5.15 Mn
Dec 31, 2023 4.10 Mn
Sep 30, 2023 3.77 Mn
Jun 30, 2023 3.85 Mn
Mar 31, 2023 4.29 Mn
Dec 31, 2022 3.62 Mn
Sep 30, 2022 3.58 Mn
Jun 30, 2022 4.07 Mn
Mar 31, 2022 3.99 Mn
Dec 31, 2021 3.34 Mn
Sep 30, 2021 2.91 Mn
API Access

Immunic Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IMUX&period=max&api_key=YOUR_API_KEY